Eagle Asset Management Inc United Therapeutics Corp Transaction History

Eagle Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$212.99 - $276.17 $1,277 - $1,657	-6 Reduced 0.06%	9,408 $2.11 Million
Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $33,775 - $45,990	-164 Reduced 1.71%	9,414 $2.62 Million
Q3 2022 Nov 07, 2022	SELL	$203.3 - $244.17 $11,384 - $13,673	-56 Reduced 0.58%	9,578 $2.01 Million
Q2 2022 Aug 10, 2022	BUY	$174.81 - $241.14 $1.68 Million - $2.32 Million	9,634 New	9,634 $2.27 Million

668

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Eagle Asset Management Inc with notifications on news.